Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound ...
Explosive demand and increased manufacturing capacity for Eli Lilly's weight-loss drug Zepbound drove the company to raise ...
Eli Lilly reported first-quarter adjusted profit that topped Wall Street's expectations. The company also hiked its full-year guidance on strong sales of its blockbuster diabetes drug Mounjaro and ...
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit. The drugmaker also hiked its ...
Walmart raised its full-year forecast and reported better-than-expected quarterly results on Thursday, betting that easing ...
17 November 2023, Berlin: View of a screen with the lettering Lilly Deutschland GmbHì. The US ... [+] pharmaceutical company Eli Lilly announced investment plans in Germany at the press conference.
Royal Caribbean lifts profit view again on cruise boom, higher prices Story by Reuters News Service • 39m ... The company now expects annual adjusted profit between $10.70 and $10.90 per share, ...
For the full year, Armstrong World Industries Inc. (AWI) has raised its outlook. It now sees adjusted earnings per share for the full year to be in the range of $5.80- $6.05, up from the previous ...